Literature DB >> 16197653

Prevalence of vitamin D inadequacy in Scottish adults with non-vertebral fragility fractures.

S J Gallacher1, C McQuillian, M Harkness, F Finlay, A P Gallagher, T Dixon.   

Abstract

BACKGROUND: It is well established that vitamin D levels are sub-optimal in the elderly and that adults with fragility fracture are more likely to have serum vitamin D levels either lower than those of control patients of similar age, or below the normal range.
OBJECTIVES: To investigate the prevalence of vitamin D inadequacy in an elderly population presenting to the South Glasgow Fracture Liaison Service with non-vertebral fragility fractures in order to assess the extent of the problem. RESEARCH DESIGN AND METHODS: The retrospective arm of this study used data from an established database to identify patients aged over 50 years admitted to South Glasgow University Hospitals over the previous 4 years with hip fracture. The prospective arm identified the first 50 patients aged over 50 presenting with a clinical non-vertebral fragility fracture with osteoporosis as measured by axial spine and/or hip DEXA (T-score < -2.5) after November 2004.
RESULTS: In the retrospective arm, 626 patients were identified from the database: mean age 80.5 years; 94% were aged over 60 and 74% were aged over 75. Data analysis was limited to 548 patients aged over 60 years with vitamin D recordings and not receiving supplementation with calcium and vitamin D. The mean vitamin D level was 24.7 nmol/L (9.9 ng/ml) SD = 17, however, it is likely that the true mean is lower since in approximately 25% of cases vitamin D levels were reported as < 15 nmol/L (effectively unrecordable). These were transcribed as 15 nmol/L in order to permit a numerical value to be calculated. In the absence of an agreement on what should constitute a diagnostic serum level of vitamin D inadequacy, a number of thresholds were considered--97.8% had vitamin D levels below 70 nmol/L and 91.6% had vitamin D levels below 50 nmol/L. There were no significant differences by patient sex, age or season of presentation. The mean age of patients in the prospective arm was 65.8 years (range 50.6-83.8), 72% were aged over 60 and 16% were aged over 75. The mean vitamin D level was 44.1 nmol/L (18.4 ng/ml) SD = 25.3; 82% had vitamin D levels below 70 nmol/L and 72% had vitamin D levels below 50 nmol/L. Although numbers were too small to justify extensive subgroup analyses, the mean vitamin D level in the 13 patients with hip fracture (34.5 nmol/L) was lower than in the 37 with non-hip fractures (48.2 nmol/L).
CONCLUSIONS: This study confirms almost universal vitamin D inadequacy among 548 elderly patients admitted to hospital with hip fracture, regardless of whether a threshold of 50 nmol/L or 70 nmol/L was used. However, among a prospective subset of 50 patients with clinical fragility fractures, especially those with non-hip fractures, the prevalence of inadequacy was substantially lower. It may be that vitamin D represents a correctable risk factor for fragility fracture in the elderly, possibly specifically for the hip.

Entities:  

Mesh:

Year:  2005        PMID: 16197653     DOI: 10.1185/030079905X59148

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  14 in total

1.  Prevalence of vitamin d deficiency in patients with hip fracture seen in an orthogeriatric service in sunny singapore.

Authors:  Rani Ramason; Natesan Selvaganapathi; Noor Hafizah Binte Ismail; Wei Chin Wong; Ganesan Naidu Rajamoney; Mei Sian Chong
Journal:  Geriatr Orthop Surg Rehabil       Date:  2014-06

2.  Modification of Potentially Inappropriate Prescribing Following Fall-Related Hospitalizations in Older Adults.

Authors:  Mary E Walsh; Fiona Boland; Frank Moriarty; Tom Fahey
Journal:  Drugs Aging       Date:  2019-05       Impact factor: 3.923

3.  The problem of low levels of vitamin D and osteoporosis: use of combination therapy with alendronic acid and colecalciferol (vitamin D3).

Authors:  Sol Epstein
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  An Asian viewpoint on the use of vitamin D and calcium in osteoporosis treatment: physician and patient attitudes and beliefs.

Authors:  Siew Pheng Chan; Boyd B Scott; Shuvayu S Sen
Journal:  BMC Musculoskelet Disord       Date:  2010-10-26       Impact factor: 2.362

5.  Hypovitaminosis D in patients with osteoporotic hip fractures.

Authors:  Maheshwar Lakkireddy; Shashi Vardhan Mudavath; Madhu Latha Karra; Abhishek J Arora
Journal:  J Clin Orthop Trauma       Date:  2018-06-22

6.  A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation.

Authors:  Alexandra Papaioannou; Courtney C Kennedy; Lora Giangregorio; George Ioannidis; Janet Pritchard; David A Hanley; Leonardo Farrauto; Justin DeBeer; Jonathan D Adachi
Journal:  BMC Musculoskelet Disord       Date:  2011-06-20       Impact factor: 2.362

Review 7.  (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.

Authors:  Debby den Uyl; Mike T Nurmohamed; Lilian Hd van Tuyl; Hennie G Raterman; Willem F Lems
Journal:  Arthritis Res Ther       Date:  2011-01-17       Impact factor: 5.156

8.  The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.

Authors:  Andrew Deane; Leonor Constancio; Ignac Fogelman; Geeta Hampson
Journal:  BMC Musculoskelet Disord       Date:  2007-01-10       Impact factor: 2.362

9.  Sub-optimal serum 25-hydroxyvitamin D level affects 2-year survival after hip fracture surgery.

Authors:  Eric Wei Liang Cher; John Carson Allen; Ing How Moo; Ean Chung Lo; Bryan Peh; Tet Sen Howe; Joyce Suang Bee Koh
Journal:  J Bone Miner Metab       Date:  2020-01-23       Impact factor: 2.626

10.  The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy.

Authors:  Gyöngyvér Kincse; József Varga; Péter Somogyi; Péter Szodoray; Péter Surányi; János Gaál
Journal:  BMC Musculoskelet Disord       Date:  2012-12-10       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.